Epinephrine access in schools requirements modified.
Summary
HF2489 modifies Minnesota’s school health and medication rules to expand and clarify student access to epinephrine auto-injectors in schools. The bill updates existing statutes governing medication in schools, individualized health plans, and stock epinephrine supplies so that students prescribed epinephrine can either possess it or have immediate access to it during the instructional day, depending on a parent and prescribing medical professional’s annual written determination. It also allows this health plan to be incorporated into a student’s 504 plan.
The bill further revises the school stock-supply law to use the updated term “epinephrine auto-injector delivery systems,” and it continues to authorize schools and districts to maintain epinephrine for emergency use when a person is experiencing anaphylaxis, even without a prescription. It preserves authority for nurses and, under certain protocols, licensed practical nurses to administer epinephrine, and it directs the commissioner of health to provide standing orders for school distribution. The bill also keeps in place liability protections for districts and their employees acting in good faith under these provisions.
Impact
HF2489 would amend Minnesota Statutes sections 121A.22, 121A.2205, and 121A.2207, affecting school medication administration policies, student health planning, and emergency allergy response procedures. It would require annual written communication from parents and prescribing professionals regarding a student’s ability to possess epinephrine or need for immediate access, and it would formalize school responsibilities for training staff and implementing individualized health plans. Schools would continue to be permitted to stock and administer epinephrine under standing orders and condition-specific protocols, with updated terminology and procedures aligned to current practice.
Sentiment
The available context suggests the bill is generally supportive and noncontroversial, with the caption indicating a straightforward effort to improve epinephrine access in schools. The bill was referred from Education Policy and re-referred to Health Finance and Policy, which is consistent with a policy-and-health coordination measure rather than a contested overhaul. No recorded votes or committee transcript excerpts are available, so there is no evidence of organized opposition in the provided materials.
Contention
No specific points of contention are documented in the supplied record. Potential areas that could raise implementation questions include whether students should be allowed to self-carry epinephrine, how schools determine when a student cannot safely possess it, what training is required for staff, and how the annual parent/medical-professional documentation process will work. However, the provided materials do not show any named opponents, amendments, or disputed provisions.